Insilico Drug Prediction and Validation of Lead Candidates on Plasmodium Falciparum Erythrocyte Membrane Protein 1(pfemp1) Against Malaria

Abstract

Malaria is an infectious disease caused by protozoan of the genus Plasmodium. It is transmitted by bite from infected female Anopheles mosquito. Plasmodium falciparum erythrocyte membrane protein 1 (PfEmp1), an antigen that is responsible for the immune evasion of the protozoan. This protein has adhesive properties that cause the infected erythrocytes to bind to the endothelial lining of the blood vessel, thus preventing the infected cells from getting filtered by the spleen. It is found that there is an interaction between the sulphate ion on the endothelial cells and NH 1 , NH 2 of Arg 1467 (A), NZ of Lys 1324 (A) and two bonds with N of Gly 1329 (A) on the protein. Inhibiting this interaction may prevent the evasive action. A Ligand with SO 4 interactive region can be used to achieve this. Computer aided drug designing techniques were used to find a new scaffold to solve the purpose. GROMACS was used to simulate the protein-Ligand interaction. It was observed that ZINC17206599 shows the best interaction and may prove to be a promising candidate drug for Malaria.

In Silico Prediction of Plasmodium falciparum Cytoadherence Inhibitors That Disrupt Interaction between gC1qR-DBLβ12 Complex

“…Furthermore, it has been suggested that PPI inhibition by peptides, peptidomimetics, or small-molecule inhibitors may have the potential to interfere with binding domains for malarial targets [14]. The PPIs involved in host pathogen interactions are considered important targets for novel anti-malarial interventions [17].…”